Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient
Open Access
- 1 February 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (3) , 434-435
- https://doi.org/10.1086/499533
Abstract
Sir—A 59-year-old white liver transplant recipient developed bilateral pneumonia on day 4 after the operation. After performing bronchoscopy with bronchoalveolar lavage, empirical therapy with piperacillin-tazobactam (4.5 g every 6 h) and levofloxacin (500 mg every 12 h) was commenced. During the subsequent 24 h, the patient's clinical condition worsened until he developed severe sepsis. Drotrecogin-α was administered, but because of the persistence of the patient's critical condition, and because no bacteria were isolated, antibiotic therapy was shifted 48 h later to meropenem (500 mg every 6 h) plus linezolid (600 mg every 12 h).Keywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia*Critical Care Medicine, 2005
- Does Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein Synthesis?Clinical Infectious Diseases, 2005
- Linezolid and rifampin: Drug interaction contrary to expectations?Clinical Pharmacology & Therapeutics, 2005
- Linezolid use associated with lactic acidosisScandinavian Journal of Infectious Diseases, 2005
- Antimicrobial Therapy in Critically Ill PatientsClinical Pharmacokinetics, 2005
- Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 casesAmerican Journal of Kidney Diseases, 2004
- Inhibition of P-Glycoprotein by Newer AntidepressantsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Linezolid-Induced Lactic AcidosisNew England Journal of Medicine, 2003